PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 12:54 AM ET

Sponsor Check › Person

Alan Crane

Related person on Form D filings · address state as listed: MA · listed Jul 27, 2009 → Sep 12, 2024

12issuers
51Form D filings
2009–2024years listed

Data last updated: Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 23, 2026, 11:57 PM ET · SEC enforcement last checked: not yet

Privacy: business-related public information only. Residential addresses are never shown; only the state from the filing.

Key records

The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.

1. Lawsuits

None found in sources searched.

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30) — federal district + bankruptcy courts; live RECAP re-check pending. State courts: not yet searched. PACER: not searched. · Last checked Oct 23, 2026, 11:57 PM ET.

State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched; State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.

Not yet searched.

Search queued. Results are added automatically; check back later or follow this page to be notified.

3. Bankruptcies

None found in sources searched.

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Last checked Oct 23, 2026, 11:57 PM ET.

State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons are made for sponsors and sponsor groups, not individual people.

5. Money to insiders and sales commissions

1 of 42 offerings reports sales commissions totalling $17,500; 0 report finder's fees; 1 reports proceeds to related persons totalling $275,000. (includes amounts the issuer reported as estimates)

SourceOffering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell it
EDGAR ↗Sep 12, 2024 D/A
File 021-498766
$0$0$0None listed on this filing
EDGAR ↗May 7, 2020 D
File 021-366438
$0$0$0None listed on this filing
EDGAR ↗Apr 7, 2020 D
File 021-364484
$0$0$0None listed on this filing
EDGAR ↗Jan 2, 2019 D
File 021-329411
$0$0$0None listed on this filing
EDGAR ↗Oct 1, 2018 D
File 021-322472
$0$0$0None listed on this filing
EDGAR ↗Aug 22, 2018 D
File 021-319773
$0$0$0None listed on this filing
EDGAR ↗Mar 16, 2018 D
File 021-307885
$0$0$0None listed on this filing
EDGAR ↗Feb 21, 2018 D
File 021-306068
$0$0$0None listed on this filing
EDGAR ↗Jan 22, 2018 D
File 021-303791
$0$0$0None listed on this filing
EDGAR ↗Sep 20, 2017 D
File 021-295080
$17,500$0$0OUISA CAPITAL LLC BrokerCheck CRD 102840 ↗
EDGAR ↗Nov 16, 2016 D
File 021-274591
$0$0$0None listed on this filing
EDGAR ↗Oct 17, 2016 D
File 021-272672
$0$0$0None listed on this filing
EDGAR ↗Sep 2, 2016 D/A
File 021-229519
$0$0$0None listed on this filing
EDGAR ↗Dec 22, 2015 D
File 021-253617
$0$0$0None listed on this filing
EDGAR ↗Dec 22, 2015 D
File 021-253679
$0$0$0None listed on this filing
EDGAR ↗Aug 6, 2015 D/A
File 021-222564
$0$0$0None listed on this filing
EDGAR ↗Aug 15, 2014 D/A
File 021-203891
$0$0$0None listed on this filing
EDGAR ↗Jun 18, 2014 D
File 021-219417
$0$0$0None listed on this filing
EDGAR ↗Apr 10, 2014 D
File 021-215310
$0$0$0None listed on this filing
EDGAR ↗Jan 31, 2014 D
File 021-211055
$0$0$0None listed on this filing
EDGAR ↗Dec 2, 2013 D/A
File 021-178849
$0$0$0None listed on this filing
EDGAR ↗Nov 21, 2013 D
File 021-206725
$0$0$0None listed on this filing
EDGAR ↗Jun 10, 2013 D
File 021-197686
$0$0$0None listed on this filing
EDGAR ↗Apr 1, 2013 D
File 021-194292
$0$0$0None listed on this filing
EDGAR ↗Mar 28, 2013 D
File 021-194118
$0$0$0None listed on this filing
EDGAR ↗Mar 18, 2013 D
File 021-193494
$0$0$0None listed on this filing
EDGAR ↗Dec 14, 2012 D
File 021-188408
$0$0$0None listed on this filing
EDGAR ↗Jun 28, 2012 D
File 021-180450
$0$0$275,000 (est.)None listed on this filing
EDGAR ↗Jun 19, 2012 D/A
File 021-159505
$0$0$0None listed on this filing
EDGAR ↗Jun 1, 2012 D
File 021-179118
$0$0$0None listed on this filing
EDGAR ↗Apr 10, 2012 D
File 021-176410
$0$0$0None listed on this filing
EDGAR ↗Dec 15, 2011 D
File 021-170146
$0$0$0None listed on this filing
EDGAR ↗Aug 10, 2011 D
File 021-164197
$0$0$0None listed on this filing
EDGAR ↗Nov 19, 2010 D
File 021-150787
$0$0$0None listed on this filing
EDGAR ↗Oct 14, 2010 D
File 021-149086
$0$0$0None listed on this filing
EDGAR ↗Oct 13, 2010 D
File 021-148928
$0$0$0None listed on this filing
EDGAR ↗Sep 17, 2010 D
File 021-147895
$0$0$0None listed on this filing
EDGAR ↗Jun 9, 2010 D
File 021-143174
$0$0$0None listed on this filing
EDGAR ↗Jun 4, 2010 D
File 021-142974
$0$0$0None listed on this filing
EDGAR ↗May 28, 2010 D
File 021-142704
$0$0$0None listed on this filing
EDGAR ↗Dec 8, 2009 D
File 021-114403
$0$0$0None listed on this filing
EDGAR ↗Jul 27, 2009 D
File 021-104032
$0$0$0None listed on this filing

As reported by the issuer on Form D (Items 12–15), latest filing per offering (one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Appears on these filings

SourceIssuerRoleFiledFormOfferingSoldInvestorsMin. investment
EDGAR ↗Seismic Therapeutic, Inc.DirectorSep 12, 2024D/A$146,279,914
similar: $500,000–$7,000,000
$146,279,91438
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗Seismic Therapeutic, Inc.DirectorDec 4, 2023D$121,279,929
similar: $500,000–$7,000,000
$121,279,92933
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗Navitor Pharmaceuticals, Inc.DirectorMay 7, 2020D$20,186,771
similar: $1,694,259–$16,000,000
$20,186,77119
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗Pandion Therapeutics Holdco LLCDirectorApr 7, 2020D$79,999,994
similar: $2,000,000–$19,999,994
$39,999,99723
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Navitor Pharmaceuticals, Inc.DirectorJan 2, 2019D$11,250,003
similar: $1,694,259–$16,000,000
$11,250,00312
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗KSQ Therapeutics, Inc.DirectorOct 1, 2018D$80,599,985
similar: $1,694,259–$16,000,000
$80,599,98516
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗SEVENTH SENSE BIOSYSTEMS, INC.DirectorAug 22, 2018D$20,483,208
similar: $2,000,000–$19,999,994
$18,458,83718
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Navitor Pharmaceuticals, Inc.DirectorMar 16, 2018D$25,000,003
similar: $1,694,259–$16,000,000
$11,250,00212
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗SEVENTH SENSE BIOSYSTEMS, INC.DirectorFeb 21, 2018D$5,500,000
similar: $2,000,000–$19,999,994
$3,459,38115
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Pandion Therapeutics, Inc.DirectorJan 22, 2018D$57,599,619
similar: $2,000,000–$19,999,994
$21,599,6275
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗SEVENTH SENSE BIOSYSTEMS, INC.DirectorSep 20, 2017D$10,000,000
similar: $2,000,000–$19,999,994
$2,500,0002
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗SEVENTH SENSE BIOSYSTEMS, INC.DirectorNov 16, 2016D$12,750,000
similar: $2,000,000–$19,999,994
$5,500,0007
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Dare Bioscience, Inc.DirectorOct 17, 2016D$1
similar: $1,694,259–$16,000,000
$11
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗XTuit Pharmaceuticals, Inc.DirectorSep 2, 2016D/A$22,016,999
similar: $1,694,259–$16,000,000
$22,016,99910
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗Navitor Pharmaceuticals, Inc.DirectorDec 22, 2015D$33,250,003
similar: $1,694,259–$16,000,000
$12,000,00111
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗SEVENTH SENSE BIOSYSTEMS, INC.DirectorDec 22, 2015D$2,060,000
similar: $2,000,000–$19,999,994
$2,060,0006
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗SEVENTH SENSE BIOSYSTEMS, INC.DirectorAug 6, 2015D/A$16,287,084
similar: $2,000,000–$19,999,994
$14,287,0848
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗XTuit Pharmaceuticals, Inc.Executive Officer, DirectorJun 11, 2015D/A$22,017,000
similar: $1,694,259–$16,000,000
$12,008,5009
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗XTuit Pharmaceuticals, Inc.Executive Officer, DirectorDec 5, 2014D$10,000,000
similar: $1,694,259–$16,000,000
$4,000,0003
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗Navitor Pharmaceuticals, Inc.DirectorAug 15, 2014D/A$23,521,560
similar: $1,694,259–$16,000,000
$13,521,56010
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗SEVENTH SENSE BIOSYSTEMS, INC.DirectorAug 8, 2014D$16,467,084
similar: $2,000,000–$19,999,994
$10,467,0848
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Navitor Pharmaceuticals, Inc.DirectorJun 26, 2014D/A$23,521,560
similar: $1,694,259–$16,000,000
$13,521,56010
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗SEVENTH SENSE BIOSYSTEMS, INC.DirectorJun 18, 2014D$450,000
similar: $2,000,000–$19,999,994
$450,0005
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗SEVENTH SENSE BIOSYSTEMS, INC.DirectorApr 10, 2014D$930,000
similar: $2,000,000–$19,999,994
$930,0005
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗XTuit Pharmaceuticals, Inc.Executive Officer, DirectorJan 31, 2014D$1,508,513
similar: $1,694,259–$16,000,000
$1,508,5132
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗Visterra, Inc.DirectorDec 2, 2013D/A$34,229,999
similar: $2,000,000–$19,999,994
$34,229,99916
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗SEVENTH SENSE BIOSYSTEMS, INC.DirectorNov 21, 2013DIndefinite
similar: $2,000,000–$19,999,994
$360,0005
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Navitor Pharmaceuticals, Inc.DirectorOct 2, 2013D$12,231,974
similar: $1,694,259–$16,000,000
$10,231,9749
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗OCULAR THERAPEUTIX, INCExecutive Officer, DirectorJun 10, 2013D$8,500,002$8,500,0022$2,000,000
EDGAR ↗SEVENTH SENSE BIOSYSTEMS, INC.DirectorApr 1, 2013D$157,500$157,5001No minimum reported
EDGAR ↗T2 Biosystems, Inc.DirectorMar 28, 2013D$399,999,997$399,999,99716No minimum reported
EDGAR ↗SEVENTH SENSE BIOSYSTEMS, INC.DirectorMar 18, 2013D$1,800,000$1,800,0005No minimum reported
EDGAR ↗Dare Bioscience, Inc.DirectorDec 14, 2012D$13,000,000$13,000,00016No minimum reported
EDGAR ↗Visterra, Inc.DirectorNov 19, 2012D/A$26,099,699$26,099,69911No minimum reported
EDGAR ↗Experiment Fund, LLCDirector
Investment Board member
Jun 28, 2012D$6,100,000$08No minimum reported
EDGAR ↗SEVENTH SENSE BIOSYSTEMS, INC.DirectorJun 19, 2012D/A$12,182,963$12,182,9636No minimum reported
EDGAR ↗SEVENTH SENSE BIOSYSTEMS, INC.DirectorJun 1, 2012D$200,000$200,0005No minimum reported
EDGAR ↗Visterra, Inc.DirectorMay 25, 2012D$19,600,000$12,906,3008No minimum reported
EDGAR ↗SEVENTH SENSE BIOSYSTEMS, INC.DirectorApr 10, 2012D$750,000$750,0005No minimum reported
EDGAR ↗Dare Bioscience, Inc.DirectorDec 15, 2011D$15,000,098$15,000,09819No minimum reported
EDGAR ↗T2 Biosystems, Inc.DirectorAug 10, 2011D$22,999,999$22,999,99914No minimum reported
EDGAR ↗SEVENTH SENSE BIOSYSTEMS, INC.DirectorMay 10, 2011D$12,182,962$6,682,9646No minimum reported
EDGAR ↗Dare Bioscience, Inc.DirectorNov 19, 2010D$23,999,989$16,499,99417No minimum reported
EDGAR ↗SEVENTH SENSE BIOSYSTEMS, INC.DirectorOct 14, 2010D$2,100,000$2,100,0006No minimum reported
EDGAR ↗Dare Bioscience, Inc.DirectorOct 13, 2010D$1,499,999$1,499,99915No minimum reported
EDGAR ↗Visterra, Inc.DirectorSep 17, 2010D$6,000,000$6,000,0007No minimum reported
EDGAR ↗Dare Bioscience, Inc.DirectorJun 9, 2010D$5,000,000$5,000,00013No minimum reported
EDGAR ↗SEVENTH SENSE BIOSYSTEMS, INC.DirectorJun 4, 2010D$1,500,000$1,500,0006No minimum reported
EDGAR ↗T2 Biosystems, Inc.DirectorMay 28, 2010D$19,999,997$14,845,00113No minimum reported
EDGAR ↗Visterra, Inc.DirectorDec 8, 2009D$3,200,000$3,200,0007No minimum reported
EDGAR ↗Dare Bioscience, Inc.DirectorJul 27, 2009D$10,000,000$10,000,00013No minimum reported

Every row is a Form D or D/A on which the issuer listed this name as a related person. Related-person names are matched on first + last name and the address state on the filing; records that share a name but could not be tied together by a second identifier are listed separately below.

"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other / 506(b) (18,678 filings); Pharmaceuticals / 506(b) (800 filings); Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other listings under the same name

Separate person records under the same name, not combined with this page. Each line says whether it is listed on an issuer this record is also listed on (a second identifier); where it is not, it could be the same person or a different one.

  • Alan L. Crane — address state NY, 1 issuer, Jul 7, 2017 → Jul 7, 2017 · no shared issuer found

Connections as of Oct 23, 2026, 5:45 PM ET

Listed alongside — 40 names on the same filings (0 management entities, 40 people)

People and management entities the issuers listed as related persons on the same Form D filings as Alan Crane. Source: the EDGAR rows in the table above. Showing the 40 with the most shared filings.

  • Robert Langer — 28 shared filings (4 issuers) · role as listed: Director · also listed on 44 other issuers
  • Peter Barton Hutt — 18 shared filings (1 issuer) · role as listed: Director · also listed on 14 other issuers
  • HOWARD WEISMAN — 15 shared filings (1 issuer) · roles as listed: Executive Officer, Director · also listed on 1 other issuer
  • HARRY WILCOX — 14 shared filings (2 issuers) · roles as listed: Director, Executive Officer · also listed on 5 other issuers
  • HOWARD BERNSTEIN — 14 shared filings (1 issuer) · role as listed: Executive Officer · also listed on 2 other issuers
  • R. ROX ANDERSON — 12 shared filings (1 issuer) · role as listed: Director · also listed on 1 other issuer
  • Ram Sasisekharan — 11 shared filings (2 issuers) · role as listed: Director
  • Kevin Bitterman — 8 shared filings (2 issuers) · roles as listed: Executive Officer, Director · also listed on 22 other issuers
  • Doug Cole — 6 shared filings (1 issuer) · role as listed: Director · also listed on 4 other issuers
  • Bryan Roberts — 6 shared filings (1 issuer) · role as listed: Director · also listed on 31 other issuers
  • Oliver Fetzer — 6 shared filings (1 issuer) · roles as listed: Executive Officer, Director
  • Robert Tepper — 6 shared filings (1 issuer) · role as listed: Director · also listed on 14 other issuers
  • Alexandra Glucksmann — 6 shared filings (1 issuer) · role as listed: Executive Officer · also listed on 3 other issuers
  • Rick Lundberg — 6 shared filings (1 issuer) · role as listed: Executive Officer
  • Karen Roberts — 5 shared filings (1 issuer) · role as listed: Executive Officer · also listed on 1 other issuer
  • Edward Kania — 5 shared filings (1 issuer) · role as listed: Director · also listed on 1 other issuer
  • Jean Silveri — 5 shared filings (1 issuer) · role as listed: Executive Officer
  • Neil Exter — 5 shared filings (1 issuer) · role as listed: Director · also listed on 6 other issuers
  • DON CHICKERING — 5 shared filings (1 issuer) · role as listed: Executive Officer
  • Marian Nakada — 5 shared filings (1 issuer) · role as listed: Director · also listed on 5 other issuers
  • George P. Vlasuk — 5 shared filings (1 issuer) · roles as listed: Executive Officer, Director
  • David Madden — 4 shared filings (1 issuer) · role as listed: Director · also listed on 2 other issuers
  • Jean-Francois Formela — 4 shared filings (1 issuer) · role as listed: Director · also listed on 25 other issuers
  • DOUG LEVINSON — 4 shared filings (2 issuers) · roles as listed: Executive Officer, Director
  • Rakesh Jain — 4 shared filings (1 issuer) · role as listed: Director
  • Vinzenz Ploerer — 4 shared filings (1 issuer) · role as listed: Director
  • DONALD HARDISON — 4 shared filings (1 issuer) · role as listed: Director
  • TIMOTHY RICHARDS — 4 shared filings (1 issuer) · role as listed: Executive Officer · also listed on 1 other issuer
  • Michael Cima — 3 shared filings (1 issuer) · role as listed: Director · also listed on 4 other issuers
  • Michael Greeley — 3 shared filings (1 issuer) · role as listed: Director · also listed on 17 other issuers
  • Brian Gallagher — 3 shared filings (1 issuer) · role as listed: Director · also listed on 6 other issuers
  • Stan Lapidus — 3 shared filings (1 issuer) · role as listed: Director · also listed on 1 other issuer
  • Steven Hall — 3 shared filings (1 issuer) · role as listed: Director · also listed on 3 other issuers
  • ROX ANDERSON — 3 shared filings (1 issuer) · role as listed: Director
  • John Creecy — 3 shared filings (1 issuer) · roles as listed: Director, Executive Officer · also listed on 2 other issuers
  • MARC CEULEMANS — 3 shared filings (1 issuer) · role as listed: Director
  • STUART BLITZ — 3 shared filings (1 issuer) · role as listed: Executive Officer
  • John McDonough — 3 shared filings (1 issuer) · roles as listed: Executive Officer, Director · also listed on 5 other issuers
  • Edward Freedman — 3 shared filings (2 issuers) · role as listed: Executive Officer · also listed on 1 other issuer
  • Shelley Chu — 2 shared filings (1 issuer) · role as listed: Director · also listed on 8 other issuers

Other offering types (Regulation A and Regulation Crowdfunding)

None found in sources searched.

Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.

Export this report as PDF (members · included free during the launch period)

Change history

No corrections have been requested for this page.

Facts from public records only, each linked to its source. No ratings, no opinions. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Alan Crane appears on a new Form D, or when a court case or SEC action is matched to them. See plans →